MedWatch

Investment fund puts millions into Oncology Venture

Danish biotech company Oncology Venture has signed a deal with a European investment fund that has committed to buy new shares in the company for the sum of approximately SEK 300 million (USD 33.02 million).

Foto: /ritzau/Lars Krabbe

Oncology Venture has entered into a financing agreement with a Luxembourg-based investment fund, which can potentially bring in the Danish biotech company up to SEK 300 million (USD 33.02 million).

The deal is comparable to a series of directed issues of convertible notes and warrants. Put shortly, the investor will continuously buy shares in Oncology Venture over a period of two years.

Læs hele artiklen

Få 14 dages fri adgang.

Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Relaterede

Seneste nyt

Ledige job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier